Abstract:Abstract 4011 Poster Board III-947 Bidirectional signaling is an essential feature of integrin αIIbβ3 function. Outside-in signal transduction mediated by αIIbβ3 is required for normal hemostasis, clot retraction, platelet aggregation and spreading. In our previous work (Blood. 2005; 105: 4345-52), we showed that αIIb-mediated outside-in signaling is enhanced in human platelets (designated VTGβ3 Δ 724) lacking the terminal 39 residues of the β3 cytoplasmic tail. This enhanced signaling was detected as thromboxane A2 (TxA2) production and granule secretion, and required ligand cross-linking of αIIbβ3 and platelet aggregation. This αIIbβ3-mediated outside-in signaling was specifically inhibited by a palmitoylated, but not a scrambled or non-palmitoylated version of a peptide corresponding to β3 cytoplasmic domain (CD) residues R724-R734. Inhibition presumably occurred because the corresponding region within the β3 CD (RKEFAKFEEER) can bind to the CD of αIIb and negatively regulate αIIb-mediated outside-in signaling. In this study, we elucidate part of the signaling pathway(s) underlying these αIIb-elicited events. The data presented here demonstrate that D3+Fg-induced TxA2 production and granule secretion by VTGβ3 Δ 724 platelets are Src family kinase(s) (SFK), PI3K, PKC and intracellular Ca2+ flux, but not ERK dependent. Further biochemical analysis demonstrated that D3+Fg treatment of control platelets ± 10U/ml apyrase and 75mM indomethacin, induced phosphorylation of ERK and slight phosphorylation of p38, but not Akt. ERK activation was not dependent on a SFK(S) or PI3K since 10mM SFK of the inhibitor PP2 and 100nM PI3K inhibitor wortmannin did not block phosphorylation of ERK. However, Akt, and p38 were intensely phosphorylated in VTGβ3 Δ 724 platelets treated with D3+Fg ± apyrase and indomethacin, meaning that activation of Akt, and p38 appears to be directly coupled to αIIb-mediated signaling, and not coupled to TxA2 and ADP-driven signaling. Phosphorylation of p38 and Akt, but not ERK, was totally blocked by 10mM PP2. Wortmannin (100nM) inhibited phosphorylation of Akt, but not P38 and ERK. Therefore, SFK-PI3K/Akt-PKC play an important role in αIIb-mediated signaling. Akt phosphorylation in VTGβ3 Δ 724 platelets stimulated by D3+Fg was also specifically inhibited by a palmitoylated β3R724-R734 peptide but not by a palmitoylated scrambled control peptide, which further proves that SFK-PI3K signaling pathway is mediated specifically by αIIb. The role of αIIb-mediated SFK-dependent PI3K/Akt signaling was investigated in normal washed platelets by stimulating those platelets with a level of the PAR4 peptide that caused secretion-dependent aggregation. The aggregation initiated αIIbβ3-mediated outside-in signaling in both mouse and human washed platelets. The PAR4 peptide-induced Akt phosphorylation, TxA2 production and granule secretion were αIIbβ3, aggregation, and PI3K-dependent, in the absence of ADP and TxA2 initiated signaling. The palmitoylated peptide β3R724-R734 (10mM), but not a control peptide blocked ATP secretion, TxA2 production and Akt phosphorylation in normal platelets stimulated with the PAR4 peptide. Therefore, the αIIb-initiated SFK(s), PI3K/Akt, PKC signaling pathway is responsible for TxA2 production and granule secretion, in both VTGβ3 Δ 724 and normal platelets. SFK-dependent p38 activation is also triggered by αIIb-mediated signaling, but it is not Akt-dependent and the function of p38 in αIIb-mediated signaling events is unknown. Finally, ERK activation is αIIbβ3-dependent, but not αIIbβ3-mediated; therefore ERK activation probably is an effect of non-αIIb-mediated contact-dependent signaling. The work presented here provides a new understanding of αIIbb3- outside-in signaling. Disclosures: No relevant conflicts of interest to declare.

Second messenger Ap 4 A polymerizes target protein HINT1 to transduce signals in FcεRI-activated mast cells

Side Chain Independent Recognition of Aminoacyl Adenylates by the Hint1 Transcription Suppressor

ACTIVATION OF ERK 1/2 AND SP1 MAY CONTRIBUTE TO THE EXPRESSION OF TISSUE INHIBITOR OF METALLOPROTEINASE-1 INDUCED BY TRANSFORMING GROWTH FACTOR-β1 IN HUMAN PULMONARY ARTERIAL SMOOTH MUSCLE CELLS

Mechano-regulation of Peptide-MHC Class I Conformations Determines TCR Antigen Recognition.

Lipid-based and protein-based interactions synergize transmembrane signaling stimulated by antigen clustering of IgE receptors

Post-translational modification of HINT1 mediates activation of MITF transcriptional activity in human melanoma cells

Importin beta plays an essential role in the regulation of the LysRS-Ap(4)A pathway in immunologically activated mast cells

High resolution mapping of mast cell membranes reveals primary and secondary domains of FcεRI and LAT

Functional Identification of the Stable Transfection C5ar Cell Line Molt-4

Modulation of mast cell function by TIM-3 signaling (HYP3P.351)

Cell permeable ITAM constructs for the modulation of mediator release in mast cells

Shp2 Activates Fyn and Ras to Regulate RBL-2H3 Mast Cell Activation Following FcεRI Aggregation

Tim-3 enhances FcεRI-proximal signaling to modulate mast cell activation

Human T cell activation through the activation-inducer molecule/CD69 enhances the activity of transcription factor AP-1.

An Αiib-Mediated Outside-in Signaling Pathway That Causes Storage Granule Secretion and Thromboxane A2 Production.

Engineered Nanostructures of Haptens Lead to Unexpected Formation of Membrane Nanotubes Connecting Rat Basophilic Leukemia Cells

Activation of Rac and tyrosine phosphorylation of cytokine receptors induced by cross-linking of integrin α4β1 and cell adhesion in hematopoietic cells

Activation of Rac and tyrosine phosphorylation of cytokine receptors induced by cross-linking of integrin alpha4beta1 and cell adhesion in hematopoietic cells.

Molecular mechanism of IgE-mediated FcεRI activation

Receptor dynamics regulates actin polymerization state through phosphorylation of cofilin in mast cells

Abstract 6594: 4-1BB: A double-edged sword for T cells